VEGF-R2/Caveolin-1 Pathway of Undifferentiated ARPE-19 Retina Cells: A Potential Target as Anti-VEGF-A Therapy in Wet AMD by Resvega, an Omega-3/Polyphenol Combination
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is one of the main causes of deterioration in vision in adults aged 55 and older. In spite of therapies, the progression of the disease is often observed without reverse vision quality. In the present study, we explored whether, in undifferentiated ARPE-19 retinal cells, a disruption of the VEGF receptors (VEGF-R)/caveolin-1 (Cav-1)/protein kinases pathway could be a target for counteracting VEGF secretion. We highlight that Resvega®, a combination of omega-3 fatty acids with an antioxidant, resveratrol, inhibits VEGF-A secretion in vitro by disrupting the dissociation of the VEGF-R2/Cav-1 complex into rafts and subsequently preventing MAPK activation. Moreover, DNA ChIP analysis reveals that this combination prevents the interaction between AP-1 and vegf-a and vegf-r2 gene promoters. By these pathways, Resvega could present a potential interest as nutritional complementation against AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Nutritional anti-VEGF intervention against wet AMD has been shown to act by preventing MAPK activation in RPE cells [ 54 ], with the involvement of NFκB [ 55 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 1×
“Despite an increasing number of reports highlighting the key role of VEGF-A in the development of blood vessels in tumors and other tissues undergoing abnormal angiogenesis [27,28], and the development of new anti-VEGF antibodies to counteract neovascularization, especially in advanced cancers or in ocular diseases (i.”
BackgroundMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467 · cited 1×
“Despite an increasing number of reports highlighting the key role of VEGF-A in the development of blood vessels in tumors and other tissues undergoing abnormal angiogenesis [27,28], and the development of new anti-VEGF antibodies to counteract neovascularization, especially in advanced cancers or in ocular diseases (i.”
BackgroundPlant Polyphenols as Dietary Antioxidants in Human Health and Disease
Pandey, K. B., & Rizvi, S. I. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.5.9498 · Cited by 3,942
Age-related macular degeneration
Lim, L. S., Mitchell, P., Seddon, J. M., Holz, F. G., & Wong, T. Y. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60282-7 · Cited by 1,717
Signal transduction by vascular endothelial growth factor receptors
Koch, S., Tugues, S., Li, X., Gualandi, L., & Claesson-Welsh, L. (2011) · Biochemical Journal · doi:10.1042/bj20110301 · Cited by 1,635
Phosphorylation of c-jun mediated by MAP kinases
Pulverer, B. J., Kyriakis, J. M., Avruch, J., Nikolakaki, E., & Woodgett, J. R. (1991) · Nature · doi:10.1038/353670a0 · Cited by 1,468
ARPE-19, A Human Retinal Pigment Epithelial Cell Line with Differentiated Properties
DUNN, K. C., AOTAKI-KEEN, A. E., PUTKEY, F. R., & HJELMELAND, L. M. (1996) · Experimental Eye Research · doi:10.1006/exer.1996.0020 · Cited by 1,330
Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M., & Karin, M. (1991) · Nature · doi:10.1038/354494a0 · Cited by 789
The Age-Related Eye Disease Study (AREDS)
(1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00031-8 · Cited by 585
VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis
Abhinand, C. S., Raju, R., Soumya, S. J., Arya, P. S., & Sudhakaran, P. R. (2016) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-016-0352-8 · Cited by 502
Resveratrol as a Chemopreventive Agent: A Promising Molecule for Fighting Cancer
Delmas, D., Lancon, A., Colin, D., Jannin, B., & Latruffe, N. (2006) · Current Drug Targets · doi:10.2174/138945006776359331 · Cited by 395
Self-citationSpilsbury, K., Garrett, K. L., Shen, W.-Y., Constable, I. J., & Rakoczy, P. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64525-7 · Cited by 394
Milanini, J., Viñals, F., Pouysségur, J., & Pagès, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18165 · Cited by 315
Kimura, Y., & Okuda, H. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.6.1844 · Cited by 313
Miller, J. W., Adamis, A. P., & Aiello, L. P. (1997) · Diabetes / Metabolism Reviews · doi:10.1002/(sici)1099-0895(199703)13:1<37::aid-dmr174>3.0.co;2-k · Cited by 297
Delmas, D., Rébé, C., Lacour, S., Filomenko, R., Athias, A., Gambert, P., Cherkaoui-Malki, M., Jannin, B., Dubrez-Daloz, L., Latruffe, N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304896200 · Cited by 291
Self-citationChong, E. W.-T. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.6.826 · Cited by 279 · cited 1×
“Indeed, a meta-analysis suggests that ω-3 fatty acids such as DHA, which are essential dietary compounds found in fish such as salmon or tuna, could reduce the risk of both early and late AMD [33].”
BackgroundLabrecque, L., Royal, I., Surprenant, D. S., Patterson, C., Gingras, D., & Béliveau, R. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-07-0379 · Cited by 275
Resveratrol: Preventing properties against vascular alterations and ageing
Delmas, D., Jannin, B., & Latruffe, N. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400098 · Cited by 269
Self-citationHuman Retinal Pigment Epithelium Cells as Functional Models for the RPE In Vivo
Ablonczy, Z., Dahrouj, M., Tang, P. H., Liu, Y., Sambamurti, K., Marmorstein, A. D., & Crosson, C. E. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8021 · Cited by 243
Feng, Y., Venema, V. J., Venema, R. C., Tsai, N., & Caldwell, R. B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9790 · Cited by 208
Ferrara, N. (2010) · Nature Medicine · doi:10.1038/nm1010-1107 · Cited by 203
Antiangiogenic mechanisms of diet-derived polyphenols
Cao, Y., Cao, R., & Bråkenhielm, E. (2002) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(02)00204-8 · Cited by 167
Delmas, D., Solary, E., & Latruffe, N. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795029708 · Cited by 161
Self-citationNovel Role of ARF6 in Vascular Endothelial Growth Factor–Induced Signaling and Angiogenesis
Ikeda, S., Ushio-Fukai, M., Zuo, L., Tojo, T., Dikalov, S., Patrushev, N. A., & Alexander, R. W. (2005) · Circulation Research · doi:10.1161/01.res.0000158286.51045.16 · Cited by 150
Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 Deacetylation
Limagne, E., Thibaudin, M., Euvrard, R., Berger, H., Chalons, P., Végan, F., Humblin, E., Boidot, R., Rébé, C., Derangère, V., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.004 · Cited by 138
Self-citationMatsumoto, T., & Mugishima, H. (2006) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13.130 · Cited by 131
Dugas, B., Charbonnier, S., Baarine, M., Ragot, K., Delmas, D., Ménétrier, F., Lherminier, J., Malvitte, L., Khalfaoui, T., Bron, A. M., et al. (2010) · European Journal of Nutrition · doi:10.1007/s00394-010-0102-2 · Cited by 116
Self-citationAP-1 transcription factor mediates VEGF-induced endothelial cell migration and proliferation
Jia, J., Ye, T., Cui, P., Hua, Q., Zeng, H., & Zhao, D. (2016) · Microvascular Research · doi:10.1016/j.mvr.2016.02.004 · Cited by 107
Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells
Tahir, S. A., Park, S., & Thompson, T. C. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.23.10138 · Cited by 102
Immunomodulation and Anti-inflammatory Roles of Polyphenols as Anticancer Agents
Ghiringhelli, F., Rébé, C., Hichami, A., & Delmas, D. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012802650048 · Cited by 90
Self-citationMechanistic insight into activation of MAPK signaling by pro-angiogenic factors
Song, M., & Finley, S. D. (2018) · BMC Systems Biology · doi:10.1186/s12918-018-0668-5 · Cited by 69
Zhang, H., He, S., Spee, C. K., Ishikawa, K., & Hinton, D. R. (2015) · Cytokine · doi:10.1016/j.cyto.2015.06.019 · Cited by 65
Richer, S., Patel, S., Sockanathan, S., Ulanski, L., Miller, L., & Podella, C. (2014) · Nutrients · doi:10.3390/nu6104404 · Cited by 60
Richer, S., Stiles, W., Ulanski, L., Carroll, D., & Podella, C. (2013) · Nutrients · doi:10.3390/nu5061989 · Cited by 57
Yu, H., Zhang, H., Zhang, X., Li, D.-Y., Xue, H., Cheng-en, P., & Zhao, S. (2010) · PubMed · Cited by 57
Development of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians
Keane, P. A., & Sadda, S. R. (2012) · Journal of Ophthalmology · doi:10.1155/2012/483034 · Cited by 51
Jiang, Y., Lin, X., Tang, Z., Lee, C., Tian, G., Du, Y., Yin, X., Ren, X., Huang, L., Ye, Z., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706394114 · Cited by 46
Wu, H., He, L., Shi, J., Hou, X., Zhang, H., Zhang, X., An, Q., & Fan, F. (2018) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13017 · Cited by 39
Querques, G., Benlian, P., Chanu, B., Portal, C., COSCAS, G. J., Soubrane, G., & Souied, E. H. (2009) · European Journal of Ophthalmology · doi:10.1177/112067210901900115 · Cited by 37
Morais, C., Ebrahem, Q., Anand‐Apte, B., & Parat, M. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.12.018 · Cited by 36
Spatial and Temporal Localization of Caveolin-1 Protein in the Developing Retina
Gu, X., Reagan, A. M., Yen, A., Bhatti, F. N., Cohen, A. W., & Elliott, M. H. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3209-8_3 · Cited by 33
Role of Plasma Membrane Caveolae/Lipid Rafts in VEGF-Induced Redox Signaling in Human Leukemia Cells
Caliceti, C., Zambonin, L., Rizzo, B., Fiorentini, D., Vieceli Dalla Sega, F., Hrelia, S., & Prata, C. (2014) · BioMed Research International · doi:10.1155/2014/857504 · Cited by 32
Bipolar assembly of caveolae in retinal pigment epithelium
Mora, R. C., Bonilha, V. L., Shin, B., Hu, J. G., Cohen‐Gould, L., Bok, D., & Rodriguez-Boulan, E. J. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00405.2005 · Cited by 30
Resvega Alleviates Hydroquinone-Induced Oxidative Stress in ARPE-19 Cells
Bhattarai, N., Korhonen, E., Toppila, M., Koskela, A. K. J., Kaarniranta, K., Mysore, Y., & Kauppinen, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062066 · Cited by 30
Seong, H., Ryu, J., JEONG, J. Y., Chung, I. Y., Han, Y., Hwang, S. H., PARK, J. M., Kang, S. S., & Seo, S. W. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3518 · Cited by 29
Targeted Lipidomic Analysis of Myoblasts by GC-MS and LC-MS/MS
Blondelle, J., de Barros, J.-P. P., Pilot‐Storck, F., & Tiret, L. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7283-8_4 · Cited by 21
Prevention and Treatment of Age-Related Macular Degeneration: An Update for Pharmacists
Marshall, L. L., & Roach, J. (2013) · The Consultant Pharmacist · doi:10.4140/tcp.n.2013.723 · Cited by 19
Bhattarai, N., Piippo, N., Ranta‐aho, S., Mysore, Y., Kaarniranta, K., & Kauppinen, A. (2021) · Antioxidants · doi:10.3390/antiox10010067 · Cited by 18
RESVEGA, by the presence of Resveratrol, inhibits retinal endothelial tube formation
Olmière, C., CLERC, A., & Leconte, L. (2013) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2013.f015.x · Cited by 3
Cited by
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
Sghaier, R., Perus, M., Cornebise, C., Courtaut, F., Scagliarini, A., Olmiere, C., Aires, V., Hermetet, F., & Delmas, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911704 · Cited by 11
Self-citation
Metadata
- Authors
- Courtaut, F., Scagliarini, A., Aires, V., Cornebise, C., Pais de Barros, J.-P., Olmiere, C., & Delmas, D.
- Affiliations
- Inserm (FR)
- Université de Bourgogne Franche-Comté, 21000 Dijon, France
- Laboratoires Thea, 12 Rue Louis-Blériot, 63000 Clermont-Ferrand, France
- Corresponding author
- Delmas, Dominique
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-19
- Volume
- 22
- Issue
- 12
- Pages
- 6590
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8234996
- OpenAlex
- W3174973673
- Cited by
- 17
- References
- 51
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 1
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Agence Nationale de la Recherche (ANR-11-LABX-0021)
- Association Nationale de la Recherche et de la Technologie
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Caveolin-1 and cellular processes
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- age-related macular degeneration, VEGF-A, VEGFR2, caveolin-1, omega-3 fatty acids, resveratrol, MAPK signaling, lipid rafts, AP-1 transcription factor, anti-VEGF therapy, dietary intervention
- MeSH terms
- Cell Line, Drug Evaluation, Preclinical, Humans, Macular Degeneration, Retina, Transcription Factor AP-1, MAP Kinase Signaling System, Vascular Endothelial Growth Factor Receptor-2, Caveolin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.